A5004547736- Inflammasome and immune disorders
- COVID-19 Clinical Research Studies
- Long-Term Effects of COVID-19
Hospital General de México
2020-2021
Abstract Multiple studies have established that hyperinflammatory response induced by SARS CoV-2 is a main cause of complications and death in infected subjects. Such dysfunctional immune has been described as dysregulated exacerbated production cytokines chemokines attracts activates inflammatory cells, which start sustain pulmonary systemic damage, thus causing lead to multi organ failure death. Therefore, we suggest blocking key inflammation receptors could help reduce migration...
Abstract Multiple studies have established that hyperinflammatory response induced by SARS CoV-2 is a main cause of complications and death in infected subjects. Such dysfunctional immune has been described as dysregulated exacerbated production cytokines chemokines attracts activates inflammatory cells, which start sustain pulmonary systemic damage, thus causing lead to multi organ failure death. Therefore, we suggest blocking key inflammation receptors could help reduce migration...
Abstract Multiple studies have established that hyperinflammatory response induced by SARS CoV-2 is a main cause of complications and death in infected subjects. Such dysfunctional immune has been described as dysregulated exacerbated production cytokines chemokines attracts activates inflammatory cells, which start sustain pulmonary systemic damage, thus causing lead to multi organ failure death. Therefore, we suggest blocking key inflammation receptors could help reduce migration...
Abstract Background : Multiple studies have now established that hyperinflammatory response induced by SARS CoV-2 is a main cause of complications and death in infected subjects. Such dysfunctional immune has been described as dysregulated exacerbated production cytokines chemokines attracts activates inflammatory cells, which start sustain pulmonary systemic damage, thus causing lead to multi organ failure death. Therefore, we suggest blocking key inflammation receptors could help reduce...